Queen's Cardio Pulmonary Unit (QCPU)

ABOUT US |  The Queen’s CardioPulmonary Unit (QCPU) is an $8 million dollar, 8000 square foot research facility that is focused on a Bench-to-Bedside philosophy with emphasis on heart, lung, blood and vascular diseases. QCPU was funded by a Canadian Foundation for Innovation (CFI) grant and opened in 2017 with Dr. Stephen Archer as the founding scientific director and Brooke Ring-Snetsinger as manager.  QCPU is comprised of a state-of-the-art basic science research facility that is complemented by an onsite Kingston Health Sciences Center (KHSC) satellite clinic with clinical trials research capacity.  Built on existing institutional investments by Queen’s University, QCPU enhances existing links between clinical and basic investigators at Queen’s and fosters new collaborations between researchers in other faculties and at other universities. QCPU is funded by the Department of Medicine, the Faculty of Health Sciences (FHS) and through cost recovery for services rendered. QCPU’s mission includes growing the extramurally funded research enterprise in the Department of Medicine and Faculty of Health Sciences at Queen’s University.

QCPU will serve as a magnet to attract physicians and scientists to Canada and provide an ideal training environment for graduate and undergraduate students.

Housed within the Bioscience Complex, located in the heart of Queen’s campus, QCPU is within close proximity to the School of Medicine Building, KHSC and other key departments within the Faculty of Health Science. QCPU embodies research excellence and will ensure that Queen's research is recognized internationally as a center for translational research.  QCPU was established as a cost-recovery funding model. We provide Queen’s researchers with the experience and access to cutting-edge technology to bring their research to the next level.

QCPU also strengthens the Queen's research community by providing expertise via our 4 research scientists and fee-for-services access to most of our state-of-the-art instrument, including flow and sorting cytometer, 2-photon confocal microscope, tri-modality micro-scanner, Next Generation Sequencing with a NexSeq 550 sequencer, and a Fluidigm Helio/Hyperion mass cytometer.  If you are interested in our services follow the link to learn more, or contact one of our scientist below.  We are committed to ensuring that research at Queen's continues to thrive and succeed.